Literature DB >> 27376551

Authors' Reply.

Helge Hebestreit1, Hubertus G M Arets, Paul Aurora, Steve Boas, Frank Cerny, Erik H J Hulzebos, Chantal Karila, Larry C Lands, John D Lowman, Anne Swisher, Don S Urquhart.   

Abstract

Entities:  

Year:  2016        PMID： 27376551      PMCID： PMC5929101          DOI： 10.1159/000447654

Source DB:  PubMed          Journal:  Respiration        ISSN： 0025-7931            Impact factor:   3.580


× No keyword cloud information.
  6 in total

1.  Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis.

Authors:  H J Hulzebos; M S Werkman; M van Brussel; T Takken
Journal:  J Cyst Fibros       Date:  2012-06-15       Impact factor: 5.482

2.  A protocol to determine valid V˙O2max in young cystic fibrosis patients.

Authors:  Zoe L Saynor; Alan R Barker; Patrick J Oades; Craig A Williams
Journal:  J Sci Med Sport       Date:  2013-03-17       Impact factor: 4.319

3.  Validity and Reliability Concerns Associated with Cardiopulmonary Exercise Testing Young People with Cystic Fibrosis.

Authors:  Zoe L Saynor; Alan R Barker; Patrick J Oades; Owen W Tomlinson; Craig A Williams
Journal:  Respiration       Date:  2016-06-30       Impact factor: 3.580

4.  Statement on Exercise Testing in Cystic Fibrosis.

Authors:  Helge Hebestreit; Hubertus G M Arets; Paul Aurora; Steve Boas; Frank Cerny; Erik H J Hulzebos; Chantal Karila; Larry C Lands; John D Lowman; Anne Swisher; Don S Urquhart
Journal:  Respiration       Date:  2015-09-09       Impact factor: 3.580

5.  Reliability of peak VO(2) and maximal cardiac output assessed using thoracic bioimpedance in children.

Authors:  Joanne Welsman; Katie Bywater; Colin Farr; Deborah Welford; Neil Armstrong
Journal:  Eur J Appl Physiol       Date:  2005-05-26       Impact factor: 3.078

6.  Reproducibility of maximal cardiopulmonary exercise testing for young cystic fibrosis patients.

Authors:  Zoe L Saynor; Alan R Barker; Patrick J Oades; Craig A Williams
Journal:  J Cyst Fibros       Date:  2013-05-28       Impact factor: 5.482
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.